Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andrey F Verbovoy"'
Autor:
Tatiana Kharitonova, Yury G Shvarts, Andrey F Verbovoy, Natalia S Orlova, Valentina P Puzyreva, Igor A Strokov
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 10, Iss 3 (2022)
Externí odkaz:
https://doaj.org/article/76ce133262d845c2a1bc32819b62d82b
Autor:
Andrey F. Verbovoy, Yulia A. Dolgikh
Publikováno v:
Consilium Medicum, Vol 26, Iss 8, Pp 516-521 (2024)
Diabetes mellitus (DM) is a non-communicable epidemic. The number of people with this pathology is growing every year. DM leads to a decrease in quality and life expectancy due to vascular complications. However, the manifestations of diabetes are va
Externí odkaz:
https://doaj.org/article/17260100c0ff459ea94539e569da6113
Publikováno v:
Ожирение и метаболизм, Vol 14, Iss 4, Pp 5-9 (2017)
Adipose tissue is an active endocrine organ secreting a number of hormones – adipokines. One of them is resistin, which is produced not only by adipocytes, but also by monocytes, macrophages, cardiomyocytes. Since the beginning of its discovery in
Externí odkaz:
https://doaj.org/article/c40a60a9856240148e1e3d8b79ac7c55
Publikováno v:
Ожирение и метаболизм, Vol 14, Iss 2, Pp 9-17 (2017)
Today an obesity became the global epidemic striking both children, and adults and represents one of the most important problems of health care worldwide. Excess accumulation of fatty tissue is resulted by insulin resistance and a compensatory hyperi
Externí odkaz:
https://doaj.org/article/6ef5987f21cd4f6fb1b9bcd888047d9c
Publikováno v:
Ожирение и метаболизм, Vol 13, Iss 1, Pp 20-24 (2016)
Aim. To study the impact of type 2 diabetes and its combination with gout on the level of adipokines, hormonal and metabolic parameters.Materials and methods. The study included 18 men with type 2 diabetes with a mean age 57,83 ± 1,67 years, and 21
Externí odkaz:
https://doaj.org/article/bbb2490462f8401785fbeb3ec9611e11
Autor:
Wim Wilpshaar, Valeria L. Orlova, Andrey F. Verbovoy, Reiner Tretter, Marina Vladimirovna Shestakova, John P.H. Wilding
Publikováno v:
DIABETES RESEARCH AND CLINICAL PRACTICE
To assess the efficacy and safety of ipragliflozin as add-on therapy to metformin in Russian patients with type 2 diabetes mellitus.In this double-blind study conducted in 14 centers in Russia, 165 patients were randomized 2:1 to ipragliflozin (50 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319d9150432b13a35829fefc6458414d
https://doi.org/10.1016/j.diabres.2018.10.018
https://doi.org/10.1016/j.diabres.2018.10.018
Publikováno v:
Ожирение и метаболизм, Vol 13, Iss 1, Pp 20-24 (2016)
Aim. To study the impact of type 2 diabetes and its combination with gout on the level of adipokines, hormonal and metabolic parameters.Materials and methods. The study included 18 men with type 2 diabetes with a mean age 57,83 ± 1,67 years, and 21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43235df8e208a6058d992d9e754eae30
https://www.omet-endojournals.ru/jour/article/view/7163
https://www.omet-endojournals.ru/jour/article/view/7163
Autor:
Reiner Tretter, Wim Wilpshaar, Andrey F. Verbovoy, Valeria L. Orlova, Marina Vladimirovna Shestakova, John P.H. Wilding
Publikováno v:
Diabetes. 67
Aim: To assess the efficacy and safety of ipragliflozin as add-on therapy to metformin in Russian patients with T2DM. Methods: In this double-blind trial conducted in 14 centers in Russia, 165 patients were randomized 2:1 to ipragliflozin (50 mg/day)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee76cc7ed85178d1edbdf849ad8a40d
https://doi.org/10.2337/db18-1131-p
https://doi.org/10.2337/db18-1131-p